Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the following geographical segments: U.S. and International. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Alimera Sciences Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Alimera Sciences Inc. market cap is $290.23M.
What is the 52-week high for Alimera Sciences Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Alimera Sciences Inc. 52 week high is $5.65 as of September 16, 2025.
What is the 52-week low for Alimera Sciences Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Alimera Sciences Inc. 52 week low is $2.77 as of September 16, 2025.
What is Alimera Sciences Inc. stock price today?
Alimera Sciences Inc. stock price today is $5.54.
What was Alimera Sciences Inc. stock price yesterday?
Alimera Sciences Inc. stock price yesterday was $5.55.
What is the PE ratio of Alimera Sciences Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Alimera Sciences Inc.’s P/E ratio is -18.13.
What is the Price-to-Book ratio of Alimera Sciences Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Alimera Sciences Inc. P/B ratio is 7.4824.
What is the 50-day moving average of Alimera Sciences Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Alimera Sciences Inc. 50-day moving average is $5.54.
